|
■Company Name |
Institute of Gene and Brain Science |
|
■Company Address |
Omori Mitsubishi Build,8F 2-3-10,Sanno Ota-ku, Tokyo,143-0023 Japan Tel:+81(3)5746-1333 Fax:+81(3)5746-2322 |
|
■Homepage Address |
http://www.ins-gbs.co.jp/en/ |
|
■Email Contact |
info@ins-gbs.co.jp |
|
■President |
Hirotugu Watabe |
|
■Principal Area of Business |
GBS is a drug discovery venture company that focuses on research and development of new drugs related to regeneration of the central nervous system and cancer immune therapy. |
|
■Principal Products/Business Activities |
l Regeneration of the Central Nervous System with development of GM-CSF as a drug for brain or spinal chord injuries
l Cancer-specific antigens |
|
■Business Goals |
To develop our numerous cancer specific antigens into candidates for cancer vaccines. |
|
■Year of Establishment |
November 22, 2001 |